MBOT Microbot Medical Inc.
Executive Summary
Three mega-passive institutional buyers (BlackRock, State Street, Fidelity) added Microbot Medical shares during Q3 2025 while one mega-passive seller (Morgan Stanley) exited almost entirely. The net buying is small in absolute dollar terms (buyers added ~$973K; sellers reduced ~$374K) and is dominated by index-fund rebalancing, not conviction-based active management. The $119M micro-cap is unprofitable and pre-commercial, making this a low-signal cluster consistent with passive fund drift rather than a coordinated bullish thesis.
Key Financial Metrics
Institutional Positions
Net institutional flow: $599.0K
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BlackRock | ADD | +52.6% | $1.5M | $686.0K |
| State Street | ADD | +50.5% | $636.0K | $287.0K |
| Fidelity | DOUBLED | +31000% | $948.00 | $945.00 |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | NEAR_EXIT | -95% | $398.0K | -$373.7K |
Actionable Insight
All participants are passive/index funds — no active conviction signal. The cluster likely reflects mechanical index rebalancing or auto-investment flows, not a shared fundamental thesis. Without an active manager catalyst or insider buying, this cluster has negligible predictive value for MBOT. Monitor for a 13D activist or strategic partnership filing for a real signal.
Key Facts
- Three mega-passive buyers added a net ~$973K in MBOT during Q3 2025; one passive seller reduced ~$374K
- BlackRock increased holdings 52.6% to $1.5M; State Street added 50.5% to $636K; Fidelity grew from a token position to $948
- Morgan Stanley cut its MBOT stake 95% to just $24K, suggesting passive rebalancing rather than a negative thesis
- Aggregate net dollar flow is ~$600K positive — immaterial for a $119M micro-cap
- All participants are mega-passive fund families; no active or activist managers participated
Financial Impact
Net institutional buying of ~$600K (buyers added ~$973K, sellers reduced ~$374K), representing <1% of MBOT's $119M market cap
Risk Factors
- MBOT has a $119M market cap, is pre-revenue, and burns cash — institutional flows this small are noise
- Passive fund additions have no demonstrated alpha for micro-cap biotech/med-device stocks
- Historical reports on MBOT show negative average T+20 returns regardless of prior report direction (0% win rate over 7 settled calls)
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-MBOT-2025-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 16, 2026
today
|
8-K
| $1.83 awaiting T+1 | awaiting T+1 | — | — |
|
Jun 11, 2026
5d ago
|
Institutional Cluster
| $1.82 $1.78 | ▼ −2.20% | ▼ −2.74% | — |
|
Jun 9, 2026
7d ago
|
8-K
| $1.82 $1.77 | ▼ −2.75% | ▼ −1.17% | — |
|
Jun 2, 2026
14d ago
|
8-K
| $2.01 $1.97 | ▼ −1.99% | ▼ −1.30% | — |
|
May 26, 2026
21d ago
|
8-K
| $1.81 $1.71 | ▼ −5.52% | ▼ −5.54% | — |
|
May 15, 2026
4w ago
|
8-K
| $1.85 $1.78 | ▼ −3.78% | ▼ −3.72% | — |
|
May 14, 2026
4w ago
|
8-K
| $1.85 $1.85 | · 0.00% | ▲ +1.23% | — |
|
May 5, 2026
6w ago
|
8-K
| $2.10 $2.19 | ▲ +4.29% | ▲ +2.90% | — |
|
Apr 22, 2026
7w ago
|
8-K
| $2.22 $2.18 | ▼ −1.80% | ▼ −1.41% | — |
|
Apr 14, 2026
9w ago
|
8-K
| $2.43 $2.39 | ▼ −1.65% | ▼ −2.42% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access